{"transactions":[{"id":730437,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T21:18:09.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":73500,"source":{"system":"sec-edgar","filing":"0001104659-26-076477","document":"tm2618497-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926076477/tm2618497-4_4seq1.xml","form_type":"4"}},{"id":730436,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":1185,"kind":"person","name":"Monia Brett P","position":1,"cik":"0001537529","reported_name":"Monia Brett P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T21:16:44.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":73500,"source":{"system":"sec-edgar","filing":"0001104659-26-076475","document":"tm2618497-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926076475/tm2618497-3_4seq1.xml","form_type":"4"}},{"id":730434,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36321,"kind":"person","name":"Wallace Peggy","position":1,"cik":"0001876466","reported_name":"Wallace Peggy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T21:14:24.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":111461,"source":{"system":"sec-edgar","filing":"0001104659-26-076472","document":"tm2618497-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926076472/tm2618497-2_4seq1.xml","form_type":"4"}},{"id":730433,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":24082,"kind":"person","name":"RICHSTONE ELLEN B","position":1,"cik":"0001281526","reported_name":"RICHSTONE ELLEN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T21:12:53.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":83500,"source":{"system":"sec-edgar","filing":"0001104659-26-076470","document":"tm2618497-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926076470/tm2618497-1_4seq1.xml","form_type":"4"}},{"id":730578,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":6,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":10,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:00:07.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":81229,"source":{"system":"sec-edgar","filing":"0001789490-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000178949026000002/primary_doc.xml","form_type":"4"}},{"id":793726,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T20:01:13.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8567,"price":1.28,"value":10965.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":618942,"source":{"system":"sec-edgar","filing":"0001104659-26-054858","document":"tm2613475-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926054858/tm2613475-1_4seq1.xml","form_type":"4"}},{"id":804406,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-20T20:18:30.000Z","date":"2026-04-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.13,"value":11300.0,"ownership":{"direct":true},"balance_after":627509,"source":{"system":"sec-edgar","filing":"0001104659-26-045511","document":"tm2612247-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926045511/tm2612247-3_4seq1.xml","form_type":"4"}},{"id":804405,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-04-20T20:16:28.000Z","date":"2026-04-16","kind":"purchase","planned":false,"acquired":true,"shares":9175,"price":1.1,"value":10092.5,"ownership":{"direct":true},"balance_after":1715851,"source":{"system":"sec-edgar","filing":"0001104659-26-045502","document":"tm2612247-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926045502/tm2612247-2_4seq1.xml","form_type":"4"}},{"id":804404,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-20T20:15:43.000Z","date":"2026-04-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.11,"value":11100.0,"ownership":{"direct":true},"balance_after":874906,"source":{"system":"sec-edgar","filing":"0001104659-26-045499","document":"tm2612247-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926045499/tm2612247-1_4seq1.xml","form_type":"4"}},{"id":896642,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-02-18T21:17:18.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5850,"price":1.12,"value":6552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1706676,"source":{"system":"sec-edgar","filing":"0001104659-26-017070","document":"tm266602-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926017070/tm266602-3_4seq1.xml","form_type":"4"}},{"id":896622,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T21:16:26.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1560,"price":1.12,"value":1747.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":617509,"source":{"system":"sec-edgar","filing":"0001104659-26-017068","document":"tm266602-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926017068/tm266602-2_4seq1.xml","form_type":"4"}},{"id":896621,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T21:15:23.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4680,"price":1.12,"value":5241.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":864906,"source":{"system":"sec-edgar","filing":"0001104659-26-017063","document":"tm266602-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926017063/tm266602-1_4seq1.xml","form_type":"4"}},{"id":917608,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-02-05T22:28:06.000Z","date":"2026-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":51704,"price":1.03,"value":53255.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":1712526,"source":{"system":"sec-edgar","filing":"0001104659-26-011075","document":"tm265419-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926011075/tm265419-3_4seq1.xml","form_type":"4"}},{"id":917607,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-02-05T22:28:06.000Z","date":"2026-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":26036,"price":1.12,"value":29160.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":1764230,"source":{"system":"sec-edgar","filing":"0001104659-26-011075","document":"tm265419-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926011075/tm265419-3_4seq1.xml","form_type":"4"}},{"id":917606,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-02-05T22:28:06.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":1790266,"source":{"system":"sec-edgar","filing":"0001104659-26-011075","document":"tm265419-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926011075/tm265419-3_4seq1.xml","form_type":"4"}},{"id":917611,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:27:19.000Z","date":"2026-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":26921,"price":1.03,"value":27728.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":619069,"source":{"system":"sec-edgar","filing":"0001104659-26-011074","document":"tm265419-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926011074/tm265419-2_4seq1.xml","form_type":"4"}},{"id":917610,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:27:19.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon\nsettlement."}],"balance_after":645990,"source":{"system":"sec-edgar","filing":"0001104659-26-011074","document":"tm265419-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926011074/tm265419-2_4seq1.xml","form_type":"4"}},{"id":917605,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:26:19.000Z","date":"2026-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":26919,"price":1.03,"value":27726.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":869586,"source":{"system":"sec-edgar","filing":"0001104659-26-011073","document":"tm265419-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926011073/tm265419-1_4seq1.xml","form_type":"4"}},{"id":917604,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:26:19.000Z","date":"2026-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11488,"price":1.12,"value":12866.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":896505,"source":{"system":"sec-edgar","filing":"0001104659-26-011073","document":"tm265419-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926011073/tm265419-1_4seq1.xml","form_type":"4"}},{"id":917603,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:26:19.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":907993,"source":{"system":"sec-edgar","filing":"0001104659-26-011073","document":"tm265419-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926011073/tm265419-1_4seq1.xml","form_type":"4"}},{"id":960859,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-12-22T21:13:36.000Z","date":"2025-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":23400,"price":1.5,"value":35100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs."}],"balance_after":990266,"source":{"system":"sec-edgar","filing":"0001104659-25-123727","document":"tm2534021-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925123727/tm2534021-3_4seq1.xml","form_type":"4"}},{"id":960858,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-12-22T21:13:36.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares earned upon the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025."}],"balance_after":1013666,"source":{"system":"sec-edgar","filing":"0001104659-25-123727","document":"tm2534021-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925123727/tm2534021-3_4seq1.xml","form_type":"4"}},{"id":960861,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:58.000Z","date":"2025-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":20280,"price":1.5,"value":30420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs."}],"balance_after":507993,"source":{"system":"sec-edgar","filing":"0001104659-25-123722","document":"tm2534021-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925123722/tm2534021-2_4seq1.xml","form_type":"4"}},{"id":960860,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:58.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares earned upon the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025."}],"balance_after":528273,"source":{"system":"sec-edgar","filing":"0001104659-25-123722","document":"tm2534021-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925123722/tm2534021-2_4seq1.xml","form_type":"4"}},{"id":960857,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:23.000Z","date":"2025-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":9360,"price":1.5,"value":14040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs."}],"balance_after":445990,"source":{"system":"sec-edgar","filing":"0001104659-25-123721","document":"tm2534021-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925123721/tm2534021-1_4seq1.xml","form_type":"4"}},{"id":960856,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:23.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares earned upon the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025."}],"balance_after":455350,"source":{"system":"sec-edgar","filing":"0001104659-25-123721","document":"tm2534021-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925123721/tm2534021-1_4seq1.xml","form_type":"4"}},{"id":1033672,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-24T01:54:11.000Z","date":"2025-09-19","kind":"exercise","planned":false,"acquired":false,"shares":7729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option was written and fully vested before the reporting persons became Section 16 insiders of the Issuer and therefore was reported on the reporting persons' Form 3 filed on October 7, 2021."}],"balance_after":0,"derivative":{"exercise_price":0.84,"expiration_date":"2025-09-22","underlying":"Common Stock","underlying_shares":7729},"source":{"system":"sec-edgar","filing":"0001104659-25-092671","document":"tm2526822-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925092671/tm2526822-1_4seq1.xml","form_type":"4"}},{"id":1033671,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-24T01:54:11.000Z","date":"2025-09-19","kind":"exercise","planned":false,"acquired":true,"shares":7729,"price":0.84,"value":6492.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Of the 56,229 shares reported as held directly by Aaron G.L. Fletcher (\"Dr. Fletcher\"), 7,729 shares, are held for the benefit of Dr. Fletcher and 48,500 shares, 34,000 of which represent restricted stock units, are held for the benefit of BP Directors, LP (\"Bios Directors\" and such securities the \"Bios Directors Securities\") under an agreement with Bios Directors pursuant to which Dr. Fletcher agreed that he will hold the Bios Directors Securities merely as a nominee for Bios Directors."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Of the 56,229 shares reported as held directly by Aaron G.L. Fletcher (\"Dr. Fletcher\"), 7,729 shares, are held for the benefit of Dr. Fletcher and 48,500 shares, 34,000 of which represent restricted stock units, are held for the benefit of BP Directors, LP (\"Bios Directors\" and such securities the \"Bios Directors Securities\") under an agreement with Bios Directors pursuant to which Dr. Fletcher agreed that he will hold the Bios Directors Securities merely as a nominee for Bios Directors."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Bios Directors may be deemed the direct or indirect beneficial owner of the Bios Directors Securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the Bios Directors Securities through his or its respective indirect interest in Bios Directors."}],"balance_after":56229,"source":{"system":"sec-edgar","filing":"0001104659-25-092671","document":"tm2526822-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925092671/tm2526822-1_4seq1.xml","form_type":"4"}},{"id":1078346,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-31T20:24:07.000Z","date":"2025-07-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":20281,"price":0.6702,"value":13592.3262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs."}],"balance_after":463273,"source":{"system":"sec-edgar","filing":"0001062993-25-013358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325013358/form4.xml","form_type":"4"}},{"id":1078345,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-31T20:24:07.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares earned upon the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025."}],"balance_after":483554,"source":{"system":"sec-edgar","filing":"0001062993-25-013358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325013358/form4.xml","form_type":"4"}},{"id":1078344,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-31T20:23:52.000Z","date":"2025-07-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":9360,"price":0.6702,"value":6273.072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs."}],"balance_after":425350,"source":{"system":"sec-edgar","filing":"0001062993-25-013357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325013357/form4.xml","form_type":"4"}},{"id":1078343,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-31T20:23:52.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares earned upon the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025."}],"balance_after":434710,"source":{"system":"sec-edgar","filing":"0001062993-25-013357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325013357/form4.xml","form_type":"4"}},{"id":1078342,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-07-31T20:23:32.000Z","date":"2025-07-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":23400,"price":0.6702,"value":15682.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs."}],"balance_after":938666,"source":{"system":"sec-edgar","filing":"0001062993-25-013356","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325013356/form4.xml","form_type":"4"}},{"id":1078341,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-07-31T20:23:32.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares earned upon the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025."}],"balance_after":962066,"source":{"system":"sec-edgar","filing":"0001062993-25-013356","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325013356/form4.xml","form_type":"4"}},{"id":1103683,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T23:22:07.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":48500,"source":{"system":"sec-edgar","filing":"0001062993-25-012082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325012082/form4.xml","form_type":"4"}},{"id":1103682,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36321,"kind":"person","name":"Wallace Peggy","position":1,"cik":"0001876466","reported_name":"Wallace Peggy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T23:21:38.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":86461,"source":{"system":"sec-edgar","filing":"0001062993-25-012081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325012081/form4.xml","form_type":"4"}},{"id":1103681,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":24082,"kind":"person","name":"RICHSTONE ELLEN B","position":1,"cik":"0001281526","reported_name":"RICHSTONE ELLEN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T23:21:06.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":58500,"source":{"system":"sec-edgar","filing":"0001062993-25-012079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325012079/form4.xml","form_type":"4"}},{"id":1103680,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":1185,"kind":"person","name":"Monia Brett P","position":1,"cik":"0001537529","reported_name":"Monia Brett P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T23:20:50.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":48500,"source":{"system":"sec-edgar","filing":"0001062993-25-012078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325012078/form4.xml","form_type":"4"}},{"id":1105083,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:38:56.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Aaron G.L. Fletcher's (\"Dr. Fletcher\") continuous service as a director as of the applicable vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":48500,"source":{"system":"sec-edgar","filing":"0001104659-25-061241","document":"tm2518563-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465925061241/tm2518563-1_4seq1.xml","form_type":"4"}},{"id":1105646,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77990,"kind":"person","name":"BP Directors, LP","position":10,"cik":"0001813311","reported_name":"BP Directors, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T17:41:08.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Aaron G.L. Fletcher's (\"Dr. Fletcher\") continuous service as a director as of the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":48500,"source":{"system":"sec-edgar","filing":"0001104659-25-061242","document":"tm2518563-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465925061242/tm2518563-2_4seq1.xml","form_type":"4"}},{"id":1161089,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-02T21:53:52.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":9692,"price":0.4472,"value":4334.2624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":404710,"source":{"system":"sec-edgar","filing":"0001062993-25-008394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325008394/form4.xml","form_type":"4"}},{"id":1263640,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-18T21:29:37.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6619,"price":0.5901,"value":3905.8719,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":887066,"source":{"system":"sec-edgar","filing":"0001062993-25-002705","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325002705/form4.xml","form_type":"4"}},{"id":1263641,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:28:44.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5296,"price":0.5901,"value":3125.1696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":418554,"source":{"system":"sec-edgar","filing":"0001062993-25-002704","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325002704/form4.xml","form_type":"4"}},{"id":1263639,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:28:23.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1723,"price":0.5901,"value":1016.7423,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":414402,"source":{"system":"sec-edgar","filing":"0001062993-25-002703","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325002703/form4.xml","form_type":"4"}},{"id":1284605,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-04T21:13:50.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share is represented by an RSU. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":423850,"source":{"system":"sec-edgar","filing":"0001062993-25-001622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325001622/form4.xml","form_type":"4"}},{"id":1284604,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-04T21:13:50.000Z","date":"2025-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":12779,"price":0.666,"value":8510.814,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."}],"balance_after":128850,"source":{"system":"sec-edgar","filing":"0001062993-25-001622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325001622/form4.xml","form_type":"4"}},{"id":1284600,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-04T21:12:56.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":416125,"source":{"system":"sec-edgar","filing":"0001062993-25-001620","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325001620/form4.xml","form_type":"4"}},{"id":1284603,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-04T21:11:53.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":631300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share is represented by an RSU. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":893685,"source":{"system":"sec-edgar","filing":"0001062993-25-001617","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325001617/form4.xml","form_type":"4"}},{"id":1284602,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-04T21:11:53.000Z","date":"2025-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":28960,"price":0.666,"value":19287.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."}],"balance_after":262385,"source":{"system":"sec-edgar","filing":"0001062993-25-001617","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325001617/form4.xml","form_type":"4"}},{"id":1284601,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-04T21:11:53.000Z","date":"2025-01-31","kind":"purchase","planned":false,"acquired":true,"shares":38851,"price":0.7722,"value":30000.7422,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7602 to $0.7816, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":38851,"source":{"system":"sec-edgar","filing":"0001062993-25-001617","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325001617/form4.xml","form_type":"4"}},{"id":1483625,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T01:32:56.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Dr. Fletcher's continuous service as a director as of the applicable vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":8500,"derivative":{"exercise_price":1.95,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001104659-24-070572","document":"tm2416970-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465924070572/tm2416970-1_4seq1.xml","form_type":"4"}},{"id":1483624,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T01:32:56.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Aaron G.L. Fletcher's (\"Dr. Fletcher\") continuous service as a director as of the applicable vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001104659-24-070572","document":"tm2416970-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465924070572/tm2416970-1_4seq1.xml","form_type":"4"}},{"id":1483371,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36321,"kind":"person","name":"Wallace Peggy","position":1,"cik":"0001876466","reported_name":"Wallace Peggy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-11T22:47:54.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":8500,"derivative":{"exercise_price":1.95,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001062993-24-012414","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324012414/form4.xml","form_type":"4"}},{"id":1483370,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36321,"kind":"person","name":"Wallace Peggy","position":1,"cik":"0001876466","reported_name":"Wallace Peggy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T22:47:54.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":52461,"source":{"system":"sec-edgar","filing":"0001062993-24-012414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324012414/form4.xml","form_type":"4"}},{"id":1483369,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-11T22:47:22.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":8500,"derivative":{"exercise_price":1.95,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001062993-24-012413","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324012413/form4.xml","form_type":"4"}},{"id":1483368,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T22:47:22.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001062993-24-012413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324012413/form4.xml","form_type":"4"}},{"id":1483367,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":24082,"kind":"person","name":"RICHSTONE ELLEN B","position":1,"cik":"0001281526","reported_name":"RICHSTONE ELLEN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-11T22:46:49.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":8500,"derivative":{"exercise_price":1.95,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001062993-24-012412","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324012412/form4.xml","form_type":"4"}},{"id":1483366,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":24082,"kind":"person","name":"RICHSTONE ELLEN B","position":1,"cik":"0001281526","reported_name":"RICHSTONE ELLEN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T22:46:49.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":24500,"source":{"system":"sec-edgar","filing":"0001062993-24-012412","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324012412/form4.xml","form_type":"4"}},{"id":1483365,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":1185,"kind":"person","name":"Monia Brett P","position":1,"cik":"0001537529","reported_name":"Monia Brett P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-11T22:46:17.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":8500,"derivative":{"exercise_price":1.95,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001062993-24-012411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324012411/form4.xml","form_type":"4"}},{"id":1483364,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":1185,"kind":"person","name":"Monia Brett P","position":1,"cik":"0001537529","reported_name":"Monia Brett P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T22:46:17.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001062993-24-012411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324012411/form4.xml","form_type":"4"}},{"id":1484233,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77990,"kind":"person","name":"BP Directors, LP","position":10,"cik":"0001813311","reported_name":"BP Directors, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-11T21:33:25.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Dr. Fletcher's continuous service as a director as of the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":8500,"derivative":{"exercise_price":1.95,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001104659-24-070573","document":"tm2416970-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465924070573/tm2416970-2_4seq1.xml","form_type":"4"}},{"id":1484232,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77990,"kind":"person","name":"BP Directors, LP","position":10,"cik":"0001813311","reported_name":"BP Directors, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T21:33:25.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Aaron G.L. Fletcher's (\"Dr. Fletcher\") continuous service as a director as of the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001104659-24-070573","document":"tm2416970-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465924070573/tm2416970-2_4seq1.xml","form_type":"4"}},{"id":1528040,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-03T20:07:05.000Z","date":"2024-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8699,"price":1.95,"value":16963.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":121125,"source":{"system":"sec-edgar","filing":"0001062993-24-009329","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324009329/form4.xml","form_type":"4"}},{"id":1576525,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-03-14T20:34:10.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":5700,"price":1.75,"value":9975.0,"ownership":{"direct":true},"balance_after":291345,"source":{"system":"sec-edgar","filing":"0001062993-24-006429","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324006429/form4.xml","form_type":"4"}},{"id":1633486,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T21:13:35.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":20000,"derivative":{"exercise_price":1.98,"expiration_date":"2034-02-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001062993-24-003651","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324003651/form4.xml","form_type":"4"}},{"id":1633485,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-20T21:13:35.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":129824,"source":{"system":"sec-edgar","filing":"0001062993-24-003651","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324003651/form4.xml","form_type":"4"}},{"id":1633484,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T21:13:22.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":60000,"derivative":{"exercise_price":1.98,"expiration_date":"2034-02-15","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001062993-24-003649","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324003649/form4.xml","form_type":"4"}},{"id":1633483,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-20T21:13:22.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":141629,"source":{"system":"sec-edgar","filing":"0001062993-24-003649","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324003649/form4.xml","form_type":"4"}},{"id":1633479,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T21:12:25.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":75000,"derivative":{"exercise_price":1.98,"expiration_date":"2034-02-15","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001062993-24-003644","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324003644/form4.xml","form_type":"4"}},{"id":1633478,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-02-20T21:12:25.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":285645,"source":{"system":"sec-edgar","filing":"0001062993-24-003644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324003644/form4.xml","form_type":"4"}},{"id":1651522,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-10T00:12:08.000Z","date":"2024-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":12777,"price":2.29,"value":29259.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":81629,"source":{"system":"sec-edgar","filing":"0001062993-24-002775","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324002775/form4.xml","form_type":"4"}},{"id":1651520,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-02-10T00:11:24.000Z","date":"2024-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":27828,"price":2.29,"value":63726.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":210645,"source":{"system":"sec-edgar","filing":"0001062993-24-002774","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299324002774/form4.xml","form_type":"4"}},{"id":1744132,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-13T14:47:16.000Z","date":"2023-11-08","kind":"grant","planned":false,"acquired":true,"shares":500095,"price":1.05,"value":525099.75,"ownership":{"direct":false,"nature":"By Bios Clinical Opportunity Fund, LP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 8, 2023, Bios Clinical Opportunity Fund, LP (\"Bios COF Fund\") purchased 500,095 shares of Common Stock in an at-the-market offering through Cantor Fitzgerald & Co. and B. Riley Securities, Inc. acting as sales agents."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Bios Equity COF, LP (\"Bios Equity COF\") is the general partner of Bios COF Fund. Bios Management is the general partner of Bios Equity COF. Dr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios COF Fund. Because of the relationship between Dr. Fletcher, Bios Management, Bios Advisors and Bios COF Fund, Dr. Fletcher, Bios Management and Bios Advisors may be deemed to beneficially own the shares held directly by Bios COF Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each reporting person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":500095,"source":{"system":"sec-edgar","filing":"0001104659-23-116868","document":"tm2330521-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465923116868/tm2330521-2_4seq1.xml","form_type":"4"}},{"id":1745121,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77990,"kind":"person","name":"BP Directors, LP","position":10,"cik":"0001813311","reported_name":"BP Directors, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-13T09:48:30.000Z","date":"2023-11-08","kind":"grant","planned":false,"acquired":true,"shares":500095,"price":1.05,"value":525099.75,"ownership":{"direct":false,"nature":"By Bios Clinical Opportunity Fund, LP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 8, 2023, Bios Clinical Opportunity Fund, LP (\"Bios COF Fund\") purchased 500,095 shares of Common Stock in an at-the-market offering through Cantor Fitzgerald & Co. and B. Riley Securities, Inc. acting as sales agents."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Bios Equity COF, LP (\"Bios Equity COF\") is the general partner of Bios COF Fund. Bios Management is the general partner of Bios Equity COF. Dr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios COF Fund. Because of the relationship between Dr. Fletcher, Bios Management, Bios Advisors and Bios COF Fund, Dr. Fletcher, Bios Management and Bios Advisors may be deemed to beneficially own the shares held directly by Bios COF Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each reporting person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":500095,"source":{"system":"sec-edgar","filing":"0001104659-23-116871","document":"tm2330521-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465923116871/tm2330521-3_4seq1.xml","form_type":"4"}},{"id":1857341,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-14T00:01:05.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Dr. Fletcher's continuous service as a director as of the applicable vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":6000,"derivative":{"exercise_price":2.77,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001104659-23-070932","document":"tm2318644-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465923070932/tm2318644-1_4seq1.xml","form_type":"4"}},{"id":1857340,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-14T00:01:05.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Aaron G.L. Fletcher's (\"Dr. Fletcher\") continuous service as a director as of the applicable vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001104659-23-070932","document":"tm2318644-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465923070932/tm2318644-1_4seq1.xml","form_type":"4"}},{"id":1857150,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":1185,"kind":"person","name":"Monia Brett P","position":1,"cik":"0001537529","reported_name":"Monia Brett P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T21:39:16.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":2.77,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001062993-23-013442","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323013442/form4.xml","form_type":"4"}},{"id":1857149,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":1185,"kind":"person","name":"Monia Brett P","position":1,"cik":"0001537529","reported_name":"Monia Brett P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T21:39:16.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001062993-23-013442","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323013442/form4.xml","form_type":"4"}},{"id":1857148,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36321,"kind":"person","name":"Wallace Peggy","position":1,"cik":"0001876466","reported_name":"Wallace Peggy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T21:38:54.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":2.77,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001062993-23-013440","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323013440/form4.xml","form_type":"4"}},{"id":1857147,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36321,"kind":"person","name":"Wallace Peggy","position":1,"cik":"0001876466","reported_name":"Wallace Peggy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T21:38:54.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":43961,"source":{"system":"sec-edgar","filing":"0001062993-23-013440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323013440/form4.xml","form_type":"4"}},{"id":1857146,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":24082,"kind":"person","name":"RICHSTONE ELLEN B","position":1,"cik":"0001281526","reported_name":"RICHSTONE ELLEN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to Buy)","published_at":"2023-06-13T21:38:15.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":2.77,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001062993-23-013439","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323013439/form4.xml","form_type":"4"}},{"id":1857145,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":24082,"kind":"person","name":"RICHSTONE ELLEN B","position":1,"cik":"0001281526","reported_name":"RICHSTONE ELLEN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T21:38:15.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001062993-23-013439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323013439/form4.xml","form_type":"4"}},{"id":1857144,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T21:37:18.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":2.77,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001062993-23-013436","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323013436/form4.xml","form_type":"4"}},{"id":1857143,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T21:37:18.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001062993-23-013436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323013436/form4.xml","form_type":"4"}},{"id":1857944,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T20:02:37.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Dr. Fletcher's continuous service as a director as of the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":6000,"derivative":{"exercise_price":2.77,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001104659-23-070933","document":"tm2318644-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465923070933/tm2318644-2_4seq1.xml","form_type":"4"}},{"id":1857943,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T20:02:37.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Aaron G.L. Fletcher's (\"Dr. Fletcher\") continuous service as a director as of the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pursuant to an agreement with BP Directors, LP (\"Bios Directors\"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (\"Bios Equity I\"), Cavu Management, LP (\"Cavu Management\"), Bios Capital Management, LP (\"Bios Management\"), Cavu Advisors LLC (\"Cavu Advisors\"), Bios Advisors GP, LLC (\"Bios Advisors\"), Leslie W. Kreis, Jr. (\"Mr. Kreis\") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001104659-23-070933","document":"tm2318644-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465923070933/tm2318644-2_4seq1.xml","form_type":"4"}},{"id":1905988,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-05-03T20:20:46.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":109824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on May 1, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":109824,"derivative":{"exercise_price":1.65,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":109824},"source":{"system":"sec-edgar","filing":"0001062993-23-010091","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323010091/form4.xml","form_type":"4"}},{"id":1905987,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":49941,"kind":"person","name":"Doyle John Brendan","position":1,"cik":"0001840738","reported_name":"Doyle John Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-03T20:20:46.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":109824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":109824,"source":{"system":"sec-edgar","filing":"0001062993-23-010091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299323010091/form4.xml","form_type":"4"}},{"id":2028328,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T21:05:40.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":94406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 33.3% on February 3, 2024, with the remaining 66.7% vesting in 24 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":94406,"derivative":{"exercise_price":2.12,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":94406},"source":{"system":"sec-edgar","filing":"0000899243-23-004184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000089924323004184/doc4.xml","form_type":"4"}},{"id":2028327,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51939,"kind":"person","name":"Caggiano Anthony","position":1,"cik":"0001892981","reported_name":"Caggiano Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-07T21:05:40.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":94406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":94406,"source":{"system":"sec-edgar","filing":"0000899243-23-004184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000089924323004184/doc4.xml","form_type":"4"}},{"id":2028325,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T21:05:22.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":213973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 33.3% on February 3, 2024, with the remaining 66.7% vesting in 24 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":213973,"derivative":{"exercise_price":2.12,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":213973},"source":{"system":"sec-edgar","filing":"0000899243-23-004182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000089924323004182/doc4.xml","form_type":"4"}},{"id":2028324,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":51940,"kind":"person","name":"Ricciardi Lisa","position":1,"cik":"0001418200","reported_name":"Ricciardi Lisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-02-07T21:05:22.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":213973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":238473,"source":{"system":"sec-edgar","filing":"0000899243-23-004182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000089924323004182/doc4.xml","form_type":"4"}},{"id":2102414,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":24082,"kind":"person","name":"RICHSTONE ELLEN B","position":1,"cik":"0001281526","reported_name":"RICHSTONE ELLEN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T21:57:01.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":10000,"price":2.655,"value":26550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. The shares were purchased at prices ranging from $2.61 to $2.67 per share. The reporting person undertakes to provide to Cognition Therapeutics, Inc., any security holder of Cognition Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001062993-22-022923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299322022923/form4.xml","form_type":"4"}},{"id":2102606,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T12:02:22.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":1871,"price":2.6497,"value":4957.5887,"ownership":{"direct":false,"nature":"By Bios Fund III, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.65, inclusive. The reporting persons undertake to provide to Cognition Therapeutics Inc., any security holder of Cognition Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bios Equity Partners, LP (\"Bios Equity I\") is the general partner of the following entities: Bios Fund I, LP (\"Bios Fund I\"), Bios Fund I QP, LP (\"Bios Fund I QP\") and Bios Memory SPV I, LP (\"Bios Memory I\").  Bios Equity Partners II, LP (\"Bios Equity II\") is the general partner of the following entities: Bios Fund II, LP (\"Bios Fund II\"), Bios Fund II QP, LP (\"Bios Fund II QP\"), Bios Fund II NT, LP (\"Bios Fund II NT\") and Bios Memory SPV II, LP (\"Bios Memory II\"). Bios Equity Partners III, LP (\"Bios Equity III\") is the general partner of the following entities: Bios Fund III, LP (\"Bios Fund III\"), Bios Fund III QP, LP (\"Bios Fund III QP\") and Bios Fund III NT, LP (\"Bios Fund III NT\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bios Capital Management, LP (\"Bios Management\") and Cavu Management, LP (\"Cavu Management\") are the general partners Bios Equity III. Bios Advisors GP, LLC (\"Bios Advisors\") is the general partner of Bios Management. Cavu Advisors LLC (\"Cavu Advisors\") is the general partner of Cavu Management. Bios Management and Bios Advisors are entities managed and controlled by Aaron G.L. Fletcher. Cavu Management and Cavu Advisors are entities managed and controlled by Leslie W. Kreis, Jr."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Kreis, Cavu Management, Cavu Advisors, Mr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios Fund I, Bios Fund I QP, Bios Memory SPV I, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Memory II, Bios Fund III, Bios Fund III QP and Bios Fund III NT (collectively, the \"Bios Equity Entities\"). Because of the relationship between Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors and the Bios Equity Entities, Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, and Bios Advisors each may be deemed to beneficially own the shares held directly by the Bios Equity Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":309748,"source":{"system":"sec-edgar","filing":"0001104659-22-122625","document":"tm2231503-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465922122625/tm2231503-2_4seq1.xml","form_type":"4"}},{"id":2102605,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T12:02:22.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":12220,"price":2.6497,"value":32379.334,"ownership":{"direct":false,"nature":"By Bios Fund III QP, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.65, inclusive. The reporting persons undertake to provide to Cognition Therapeutics Inc., any security holder of Cognition Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bios Equity Partners, LP (\"Bios Equity I\") is the general partner of the following entities: Bios Fund I, LP (\"Bios Fund I\"), Bios Fund I QP, LP (\"Bios Fund I QP\") and Bios Memory SPV I, LP (\"Bios Memory I\").  Bios Equity Partners II, LP (\"Bios Equity II\") is the general partner of the following entities: Bios Fund II, LP (\"Bios Fund II\"), Bios Fund II QP, LP (\"Bios Fund II QP\"), Bios Fund II NT, LP (\"Bios Fund II NT\") and Bios Memory SPV II, LP (\"Bios Memory II\"). Bios Equity Partners III, LP (\"Bios Equity III\") is the general partner of the following entities: Bios Fund III, LP (\"Bios Fund III\"), Bios Fund III QP, LP (\"Bios Fund III QP\") and Bios Fund III NT, LP (\"Bios Fund III NT\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bios Capital Management, LP (\"Bios Management\") and Cavu Management, LP (\"Cavu Management\") are the general partners Bios Equity III. Bios Advisors GP, LLC (\"Bios Advisors\") is the general partner of Bios Management. Cavu Advisors LLC (\"Cavu Advisors\") is the general partner of Cavu Management. Bios Management and Bios Advisors are entities managed and controlled by Aaron G.L. Fletcher. Cavu Management and Cavu Advisors are entities managed and controlled by Leslie W. Kreis, Jr."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Kreis, Cavu Management, Cavu Advisors, Mr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios Fund I, Bios Fund I QP, Bios Memory SPV I, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Memory II, Bios Fund III, Bios Fund III QP and Bios Fund III NT (collectively, the \"Bios Equity Entities\"). Because of the relationship between Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors and the Bios Equity Entities, Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, and Bios Advisors each may be deemed to beneficially own the shares held directly by the Bios Equity Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":2021906,"source":{"system":"sec-edgar","filing":"0001104659-22-122625","document":"tm2231503-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465922122625/tm2231503-2_4seq1.xml","form_type":"4"}},{"id":2102604,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T12:02:22.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":1973,"price":2.6497,"value":5227.8581,"ownership":{"direct":false,"nature":"By Bios Fund III NT, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.65, inclusive. The reporting persons undertake to provide to Cognition Therapeutics Inc., any security holder of Cognition Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bios Equity Partners, LP (\"Bios Equity I\") is the general partner of the following entities: Bios Fund I, LP (\"Bios Fund I\"), Bios Fund I QP, LP (\"Bios Fund I QP\") and Bios Memory SPV I, LP (\"Bios Memory I\").  Bios Equity Partners II, LP (\"Bios Equity II\") is the general partner of the following entities: Bios Fund II, LP (\"Bios Fund II\"), Bios Fund II QP, LP (\"Bios Fund II QP\"), Bios Fund II NT, LP (\"Bios Fund II NT\") and Bios Memory SPV II, LP (\"Bios Memory II\"). Bios Equity Partners III, LP (\"Bios Equity III\") is the general partner of the following entities: Bios Fund III, LP (\"Bios Fund III\"), Bios Fund III QP, LP (\"Bios Fund III QP\") and Bios Fund III NT, LP (\"Bios Fund III NT\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bios Capital Management, LP (\"Bios Management\") and Cavu Management, LP (\"Cavu Management\") are the general partners Bios Equity III. Bios Advisors GP, LLC (\"Bios Advisors\") is the general partner of Bios Management. Cavu Advisors LLC (\"Cavu Advisors\") is the general partner of Cavu Management. Bios Management and Bios Advisors are entities managed and controlled by Aaron G.L. Fletcher. Cavu Management and Cavu Advisors are entities managed and controlled by Leslie W. Kreis, Jr."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Kreis, Cavu Management, Cavu Advisors, Mr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios Fund I, Bios Fund I QP, Bios Memory SPV I, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Memory II, Bios Fund III, Bios Fund III QP and Bios Fund III NT (collectively, the \"Bios Equity Entities\"). Because of the relationship between Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors and the Bios Equity Entities, Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, and Bios Advisors each may be deemed to beneficially own the shares held directly by the Bios Equity Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":326733,"source":{"system":"sec-edgar","filing":"0001104659-22-122625","document":"tm2231503-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465922122625/tm2231503-2_4seq1.xml","form_type":"4"}},{"id":2102932,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T07:00:39.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":1871,"price":2.6497,"value":4957.5887,"ownership":{"direct":false,"nature":"By Bios Fund III, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.65, inclusive. The reporting persons undertake to provide to Cognition Therapeutics Inc., any security holder of Cognition Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bios Equity Partners, LP (\"Bios Equity I\") is the general partner of the following entities: Bios Fund I, LP (\"Bios Fund I\"), Bios Fund I QP, LP (\"Bios Fund I QP\") and Bios Memory SPV I, LP (\"Bios Memory I\"). Bios Equity Partners II, LP (\"Bios Equity II\") is the general partner of the following entities: Bios Fund II, LP (\"Bios Fund II\"), Bios Fund II QP, LP (\"Bios Fund II QP\"), Bios Fund II NT, LP (\"Bios Fund II NT\") and Bios Memory SPV II, LP (\"Bios Memory II\"). Bios Equity Partners III, LP (\"Bios Equity III\") is the general partner of the following entities: Bios Fund III, LP (\"Bios Fund III\"), Bios Fund III QP, LP (\"Bios Fund III QP\") and Bios Fund III NT, LP (\"Bios Fund III NT\"). Bios Capital Management, LP (\"Bios Management\") and Cavu Management, LP (\"Cavu Management\") are the general partners Bios Equity III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bios Advisors GP, LLC (\"Bios Advisors\") is the general partner of Bios Management. Cavu Advisors LLC (\"Cavu Advisors\") is the general partner of Cavu Management. Bios Management and Bios Advisors are entities managed and controlled by Aaron G.L. Fletcher. Cavu Management and Cavu Advisors are entities managed and controlled by Leslie W. Kreis, Jr."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Kreis, Cavu Management, Cavu Advisors, Mr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios Fund I, Bios Fund I QP, Bios Memory SPV I, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Memory II, Bios Fund III, Bios Fund III QP and Bios Fund III NT (collectively, the \"Bios Equity Entities\"). Because of the relationship between Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors and the Bios Equity Entities, Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, and Bios Advisors each may be deemed to beneficially own the shares held directly by the Bios Equity Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":309748,"source":{"system":"sec-edgar","filing":"0001104659-22-122622","document":"tm2231503-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465922122622/tm2231503-1_4seq1.xml","form_type":"4"}},{"id":2102931,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T07:00:39.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":12220,"price":2.6497,"value":32379.334,"ownership":{"direct":false,"nature":"By Bios Fund III QP, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.65, inclusive. The reporting persons undertake to provide to Cognition Therapeutics Inc., any security holder of Cognition Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bios Equity Partners, LP (\"Bios Equity I\") is the general partner of the following entities: Bios Fund I, LP (\"Bios Fund I\"), Bios Fund I QP, LP (\"Bios Fund I QP\") and Bios Memory SPV I, LP (\"Bios Memory I\"). Bios Equity Partners II, LP (\"Bios Equity II\") is the general partner of the following entities: Bios Fund II, LP (\"Bios Fund II\"), Bios Fund II QP, LP (\"Bios Fund II QP\"), Bios Fund II NT, LP (\"Bios Fund II NT\") and Bios Memory SPV II, LP (\"Bios Memory II\"). Bios Equity Partners III, LP (\"Bios Equity III\") is the general partner of the following entities: Bios Fund III, LP (\"Bios Fund III\"), Bios Fund III QP, LP (\"Bios Fund III QP\") and Bios Fund III NT, LP (\"Bios Fund III NT\"). Bios Capital Management, LP (\"Bios Management\") and Cavu Management, LP (\"Cavu Management\") are the general partners Bios Equity III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bios Advisors GP, LLC (\"Bios Advisors\") is the general partner of Bios Management. Cavu Advisors LLC (\"Cavu Advisors\") is the general partner of Cavu Management. Bios Management and Bios Advisors are entities managed and controlled by Aaron G.L. Fletcher. Cavu Management and Cavu Advisors are entities managed and controlled by Leslie W. Kreis, Jr."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Kreis, Cavu Management, Cavu Advisors, Mr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios Fund I, Bios Fund I QP, Bios Memory SPV I, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Memory II, Bios Fund III, Bios Fund III QP and Bios Fund III NT (collectively, the \"Bios Equity Entities\"). Because of the relationship between Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors and the Bios Equity Entities, Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, and Bios Advisors each may be deemed to beneficially own the shares held directly by the Bios Equity Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":2021906,"source":{"system":"sec-edgar","filing":"0001104659-22-122622","document":"tm2231503-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465922122622/tm2231503-1_4seq1.xml","form_type":"4"}},{"id":2102930,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":77970,"kind":"person","name":"Kreis Leslie W.","position":1,"cik":"0001813316","reported_name":"Kreis Leslie W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77971,"kind":"person","name":"Cavu Advisors, LLC","position":2,"cik":"0001813310","reported_name":"Cavu Advisors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77972,"kind":"person","name":"Cavu Management, LP","position":3,"cik":"0001813270","reported_name":"Cavu Management, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77973,"kind":"person","name":"BIOS Fund II NT, LP","position":4,"cik":"0001728851","reported_name":"BIOS Fund II NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78302,"kind":"person","name":"BIOS Memory SPV II, LP","position":5,"cik":"0001666485","reported_name":"BIOS Memory SPV II, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78022,"kind":"person","name":"BIOS Equity Partners III, LP","position":6,"cik":"0001831976","reported_name":"BIOS Equity Partners III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78016,"kind":"person","name":"BIOS Fund III, LP","position":7,"cik":"0001791917","reported_name":"BIOS Fund III, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78017,"kind":"person","name":"BIOS Fund III QP, LP","position":8,"cik":"0001791916","reported_name":"BIOS Fund III QP, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78018,"kind":"person","name":"BIOS Fund III NT, LP","position":9,"cik":"0001791910","reported_name":"BIOS Fund III NT, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T07:00:39.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":1973,"price":2.6497,"value":5227.8581,"ownership":{"direct":false,"nature":"By Bios Fund III NT, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.65, inclusive. The reporting persons undertake to provide to Cognition Therapeutics Inc., any security holder of Cognition Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bios Equity Partners, LP (\"Bios Equity I\") is the general partner of the following entities: Bios Fund I, LP (\"Bios Fund I\"), Bios Fund I QP, LP (\"Bios Fund I QP\") and Bios Memory SPV I, LP (\"Bios Memory I\"). Bios Equity Partners II, LP (\"Bios Equity II\") is the general partner of the following entities: Bios Fund II, LP (\"Bios Fund II\"), Bios Fund II QP, LP (\"Bios Fund II QP\"), Bios Fund II NT, LP (\"Bios Fund II NT\") and Bios Memory SPV II, LP (\"Bios Memory II\"). Bios Equity Partners III, LP (\"Bios Equity III\") is the general partner of the following entities: Bios Fund III, LP (\"Bios Fund III\"), Bios Fund III QP, LP (\"Bios Fund III QP\") and Bios Fund III NT, LP (\"Bios Fund III NT\"). Bios Capital Management, LP (\"Bios Management\") and Cavu Management, LP (\"Cavu Management\") are the general partners Bios Equity III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bios Advisors GP, LLC (\"Bios Advisors\") is the general partner of Bios Management. Cavu Advisors LLC (\"Cavu Advisors\") is the general partner of Cavu Management. Bios Management and Bios Advisors are entities managed and controlled by Aaron G.L. Fletcher. Cavu Management and Cavu Advisors are entities managed and controlled by Leslie W. Kreis, Jr."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Kreis, Cavu Management, Cavu Advisors, Mr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios Fund I, Bios Fund I QP, Bios Memory SPV I, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Memory II, Bios Fund III, Bios Fund III QP and Bios Fund III NT (collectively, the \"Bios Equity Entities\"). Because of the relationship between Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors and the Bios Equity Entities, Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, and Bios Advisors each may be deemed to beneficially own the shares held directly by the Bios Equity Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":326733,"source":{"system":"sec-edgar","filing":"0001104659-22-122622","document":"tm2231503-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1791910/000110465922122622/tm2231503-1_4seq1.xml","form_type":"4"}},{"id":2112365,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":36358,"kind":"person","name":"Fletcher Aaron G.L.","position":1,"cik":"0001789490","reported_name":"Fletcher Aaron G.L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36359,"kind":"person","name":"BIOS Capital Management, LP","position":2,"cik":"0001813845","reported_name":"BIOS Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36360,"kind":"person","name":"BIOS Advisors GP, LLC","position":3,"cik":"0001813844","reported_name":"BIOS Advisors GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36361,"kind":"person","name":"Bios Equity Partners, LP","position":4,"cik":"0001813314","reported_name":"Bios Equity Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36362,"kind":"person","name":"BIOS Fund I, LP","position":5,"cik":"0001697316","reported_name":"BIOS Fund I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36367,"kind":"person","name":"BIOS Fund I QP, LP","position":6,"cik":"0001700297","reported_name":"BIOS Fund I QP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36364,"kind":"person","name":"BIOS Memory SPV I, LP","position":7,"cik":"0001643749","reported_name":"BIOS Memory SPV I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36365,"kind":"person","name":"Bios Equity Partners II, LP","position":8,"cik":"0001813313","reported_name":"Bios Equity Partners II, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36366,"kind":"person","name":"BIOS Fund II, LP","position":9,"cik":"0001714576","reported_name":"BIOS Fund II, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36363,"kind":"person","name":"BIOS Fund II QP, LP","position":10,"cik":"0001716869","reported_name":"BIOS Fund II QP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-17T12:00:50.000Z","date":"2022-11-16","kind":"purchase","acquired":true,"shares":8269,"price":1.4,"value":11576.6,"ownership":{"direct":false,"nature":"Bios Fund III, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.23 to $1.54, inclusive. The reporting persons undertake to provide to Cognition Therapeutics Inc., any security holder of Cognition Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bios Equity Partners, LP (\"Bios Equity I\") is the general partner of the following entities: Bios Fund I, LP (\"Bios Fund I\"), Bios Fund I QP, LP (\"Bios Fund I QP\") and Bios Memory SPV I, LP (\"Bios Memory I\"). Bios Equity Partners II, LP (\"Bios Equity II\") is the general partner of the following entities: Bios Fund II, LP (\"Bios Fund II\"), Bios Fund II QP, LP (\"Bios Fund II QP\"), Bios Fund II NT, LP (\"Bios Fund II NT\") and Bios Memory SPV II, LP (\"Bios Memory II\"). Bios Equity Partners III, LP (\"Bios Equity III\") is the general partner of the following entities: Bios Fund III, LP (\"Bios Fund III\"), Bios Fund III QP, LP (\"Bios Fund III QP\") and Bios Fund III NT, LP (\"Bios Fund III NT\"). Bios Capital Management, LP (\"Bios Management\") and Cavu Management, LP (\"Cavu Management\") are the general partners Bios Equity III. Bios Advisors GP, LLC (\"Bios Advisors\") is the general partner of Bios Management. Cavu Advisors LLC (\"Cavu Advisors\") is the general partner of Cavu Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bios Management and Bios Advisors are entities managed and controlled by Aaron G.L. Fletcher. Cavu Management and Cavu Advisors are entities managed and controlled by Leslie W. Kreis, Jr."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Kries, Cavu Management, Cavu Advisors, Mr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios Fund I, Bios Fund I QP, Bios Memory SPV I, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Memory II, Bios Fund III, Bios Fund III QP and Bios Fund III NT (collectively, the \"Bios Equity Entities\"). Because of the relationship between Mr. Kries, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors and the Bios Equity Entities, Mr. Kries, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, and Bios Advisors each may be deemed to beneficially own the shares held directly by the Bios Equity Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":307877,"source":{"system":"sec-edgar","filing":"0001104659-22-119721","document":"tm2230532-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813845/000110465922119721/tm2230532-4_4seq1.xml","form_type":"4"}}],"next_cursor":"2022-11-17T12:00:50.000000Z,2112365"}